Mednax Inc Stock Analysis
MD Stock | USD 14.96 0.19 1.29% |
Mednax Inc is undervalued with Real Value of 15.58 and Target Price of 14.5. The main objective of Mednax stock analysis is to determine its intrinsic value, which is an estimate of what Mednax Inc is worth, separate from its market price. There are two main types of Mednax's stock analysis: fundamental analysis and technical analysis.
The Mednax stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mednax's ongoing operational relationships across important fundamental and technical indicators.
Mednax |
Mednax Stock Analysis Notes
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednax Inc has Price/Earnings To Growth (PEG) ratio of 0.88. The entity recorded a loss per share of 2.34. The firm had not issued any dividends in recent years. Mednax had 2:1 split on the 20th of December 2013. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people. To find out more about Mednax Inc contact James MD at 954 384 0175 or learn more at https://www.pediatrix.com.Mednax Quarterly Total Revenue |
|
Mednax Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mednax's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mednax Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mednax Inc appears to be risky and price may revert if volatility continues | |
The company generated the yearly revenue of 1.99 B. Annual Net Loss to common stockholders was (60.41 M) with gross profit of 467.03 M. | |
Over 98.0% of the company shares are owned by institutional investors | |
Latest headline from thelincolnianonline.com: Pediatrix Medical Group Downgraded by StockNews.com to Hold |
Mednax Inc Upcoming and Recent Events
16th of February 2024 Upcoming Quarterly Report | View | |
7th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
16th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Mednax Largest EPS Surprises
Earnings surprises can significantly impact Mednax's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2001-08-08 | 2001-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2001-05-08 | 2001-03-31 | 0.05 | 0.06 | 0.01 | 20 | ||
1998-07-30 | 1998-06-30 | 0.1 | 0.11 | 0.01 | 10 |
Mednax Environmental, Social, and Governance (ESG) Scores
Mednax's ESG score is a quantitative measure that evaluates Mednax's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mednax's operations that may have significant financial implications and affect Mednax's stock price as well as guide investors towards more socially responsible investments.
Mednax Thematic Classifications
In addition to having Mednax stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Mednax Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Amvescap Plc. | 2024-06-30 | 1.4 M | Segall Bryant & Hamill | 2024-09-30 | 1.2 M | Caspian Capital Partners, L.p. | 2024-09-30 | 1.1 M | Citadel Advisors Llc | 2024-09-30 | 1.1 M | Jpmorgan Chase & Co | 2024-06-30 | 1 M | Aqr Capital Management Llc | 2024-06-30 | 942.4 K | Dana Investment Advisors Inc | 2024-09-30 | 915.6 K | Weiss Asset Management Lp | 2024-09-30 | 912.8 K | Bank Of America Corp | 2024-06-30 | 899.9 K | Blackrock Inc | 2024-06-30 | 13.7 M | Vanguard Group Inc | 2024-09-30 | 10.7 M |
Mednax Market Capitalization
The company currently falls under 'Mid-Cap' category with a market capitalization of 1.28 B.Mednax Profitablity
The company has Net Profit Margin (PM) of (0.13) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.1 %, which signifies that for every $100 of sales, it has a net operating income of $0.1.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.07) | (0.07) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.07) | (0.07) |
Management Efficiency
Mednax Inc has Return on Asset (ROA) of 0.0467 % which means that for every $100 of assets, it generated a profit of $0.0467. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.2986) %, which implies that it produced no returns to current stockholders. Mednax's management efficiency ratios could be used to measure how well Mednax manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.07. In addition to that, Return On Capital Employed is expected to decline to 0. At present, Mednax's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 86.3 M, whereas Other Assets are forecasted to decline to about 212.4 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 10.11 | 9.67 | |
Tangible Book Value Per Share | (6.62) | (6.95) | |
Enterprise Value Over EBITDA | 47.17 | 49.53 | |
Price Book Value Ratio | 0.92 | 0.87 | |
Enterprise Value Multiple | 47.17 | 49.53 | |
Price Fair Value | 0.92 | 0.87 | |
Enterprise Value | 1.3 B | 1.2 B |
Management at Mednax Inc focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Operating Margin 0.1026 | Profit Margin (0.13) | Beta 1.555 | Return On Assets 0.0467 | Return On Equity (0.30) |
Technical Drivers
As of the 1st of December, Mednax secures the Risk Adjusted Performance of 0.1205, mean deviation of 1.95, and Downside Deviation of 1.84. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mednax Inc, as well as the relationship between them. Please verify Mednax Inc treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mednax Inc is priced some-what accurately, providing market reflects its recent price of 14.96 per share. Given that Mednax Inc has jensen alpha of 0.3028, we recommend you to check Mednax's last-minute market performance to make sure the company can sustain itself at a future point.Mednax Inc Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mednax middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mednax Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Mednax Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mednax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mednax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mednax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mednax Outstanding Bonds
Mednax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mednax Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mednax bonds can be classified according to their maturity, which is the date when Mednax Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
US58506YAS19 Corp BondUS58506YAS19 | View | |
MEDTRONIC INC 4375 Corp BondUS585055BT26 | View | |
MEDTRONIC INC 4625 Corp BondUS585055BU98 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
US58502BAE65 Corp BondUS58502BAE65 | View |
Mednax Predictive Daily Indicators
Mednax intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mednax stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Mednax Corporate Filings
F4 | 14th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 31st of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F3 | 4th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 3rd of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 29th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Mednax Forecast Models
Mednax's time-series forecasting models are one of many Mednax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mednax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Mednax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mednax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mednax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mednax. By using and applying Mednax Stock analysis, traders can create a robust methodology for identifying Mednax entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.02) | (0.02) | |
Net Loss | (0.03) | (0.03) | |
Gross Profit Margin | 0.21 | 0.20 |
Current Mednax Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mednax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mednax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
14.5 | Buy | 7 | Odds |
Most Mednax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mednax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mednax Inc, talking to its executives and customers, or listening to Mednax conference calls.
Mednax Stock Analysis Indicators
Mednax Inc stock analysis indicators help investors evaluate how Mednax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mednax shares will generate the highest return on investment. By understating and applying Mednax stock analysis, traders can identify Mednax position entry and exit signals to maximize returns.
Begin Period Cash Flow | 9.8 M | |
Long Term Debt | 611.6 M | |
Common Stock Shares Outstanding | 82.2 M | |
Total Stockholder Equity | 849.1 M | |
Tax Provision | 12 M | |
Quarterly Earnings Growth Y O Y | -0.112 | |
Property Plant And Equipment Net | 145.9 M | |
Cash And Short Term Investments | 177.7 M | |
Cash | 73.3 M | |
Accounts Payable | 34.6 M | |
Net Debt | 628.4 M | |
50 Day M A | 13.2514 | |
Total Current Liabilities | 388.9 M | |
Other Operating Expenses | 2 B | |
Non Current Assets Total | 1.7 B | |
Forward Price Earnings | 9.6618 | |
Non Currrent Assets Other | 82.2 M | |
Stock Based Compensation | 12.3 M |
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world |